GFUS (NM_003313) Human Mass Spec Standard

CAT#: PH310643

TSTA3 MS Standard C13 and N15-labeled recombinant protein (NP_003304)



  View other "GFUS" proteins (4)

Need it in bulk or customized?
Get a free quote

CNY 14,250.00


货期*
5周

规格
    • 10 ug

Product images

经常一起买 (2)
Transient overexpression lysate of tissue specific transplantation antigen P35B (TSTA3)
    • 100 ug

CNY 3,080.00


Rabbit Polyclonal Anti-TSTA3 Antibody - N-terminal region
    • 50 ug

CNY 4,628.00

Specifications

Product Data
Description TSTA3 MS Standard C13 and N15-labeled recombinant protein (NP_003304)
Species Human
Expression Host HEK293
Expression cDNA Clone or AA Sequence RC210643
Predicted MW 35.9 kDa
Protein Sequence
Tag C-Myc/DDK
Purity > 80% as determined by SDS-PAGE and Coomassie blue staining
Concentration >0.05 µg/µL as determined by microplate BCA method
Labeling Method Labeled with [U- 13C6, 15N4]-L-Arginine and [U- 13C6, 15N2]-L-Lysine
Buffer 25 mM Tris-HCl, 100 mM glycine, pH 7.3
Reference Data
RefSeq NP_003304
RefSeq Size 1363
RefSeq ORF 963
Synonyms FX; P35B; SDR4E1; TSTA3
Locus ID 7264
Cytogenetics 8q24.3
Summary Tissue specific transplantation antigen P35B is a NADP(H)-binding protein. It catalyze the two-step epimerase and the reductase reactions in GDP-D-mannose metabolism, converting GDP-4-keto-6-D-deoxymannose to GDP-L-fucose. GDP-L-fucose is the substrate of several fucosyltransferases involved in the expression of many glycoconjugates, including blood group ABH antigens and developmental adhesion antigens. Mutations in this gene may cause leukocyte adhesion deficiency, type II. [provided by RefSeq, Jul 2008]
Protein Families Druggable Genome
Protein Pathways Amino sugar and nucleotide sugar metabolism, Fructose and mannose metabolism, Metabolic pathways
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Documents

Other Versions

Customer Reviews 
Loading...